Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Jan 30, 2026 → Apr 30, 2026
Expand a category to see the positions behind it, ranked by weight.
No positions in this category.
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | 63,278 | 0 | -63,278 | 0.00% | -$979.86K |
| AMICUS THERAPEUTICS INC | 64,777 | 0 | -64,777 | 0.00% | -$925.66K |
| DAY ONE BIOPHARMACEUTICALS INC | 81,747 | 0 | -81,747 | 0.00% | -$912.30K |
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| IMMUNITYBIO INC | 289,581 | 401,005 | 111,424 | 4.68% | $1.04M |
| APELLIS PHARMACEUTICALS INC | 27,086 | 37,509 | 10,423 | 2.52% | $924.39K |
| KALVISTA PHARMACEUTICALS INC | 40,414 | 55,964 | 15,550 | 2.45% | $861.14K |
| MODERNA INC | 23,197 | 32,122 | 8,925 | 2.42% | $453.39K |
| IOVANCE BIOTHERAPEUTICS INC | 310,641 | 430,167 | 119,526 | 2.37% | $653.23K |
| MIRUM PHARMACEUTICALS INC | 10,513 | 14,558 | 4,045 | 2.33% | $331.49K |
| AXSOME THERAPEUTICS INC | 4,611 | 6,386 | 1,775 | 2.18% | $477.11K |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 16,432 | 22,754 | 6,322 | 2.01% | $502.02K |
| ROIVANT SCIENCES LTD | 30,922 | 42,821 | 11,899 | 2.01% | $553.15K |
| ZAI LAB LTD UNSPNRD ADR | 38,457 | 53,256 | 14,799 | 1.89% | $514.07K |
| LIGAND PHARMACEUTICALS | 3,605 | 4,992 | 1,387 | 1.88% | $452.89K |
| BIOCRYST PHARMACEUTICALS INC | 90,278 | 125,015 | 34,737 | 1.88% | $551.11K |
| TRAVERE THERAPEUTICS INC | 19,620 | 27,170 | 7,550 | 1.88% | $534.41K |
| NOVAVAX INC | 104,019 | 144,044 | 40,025 | 1.88% | $221.50K |
| UNITED THERAPEUTICS CORP DEL | 1,382 | 1,914 | 532 | 1.80% | $444.73K |
| GERON CORP | 502,509 | 695,861 | 193,352 | 1.76% | $383.19K |
| BIONTECH SE ADR | 7,207 | 9,981 | 2,774 | 1.70% | $212.74K |
| AMGEN INC | 2,150 | 2,977 | 827 | 1.69% | $295.74K |
| EXELIXIS INC | 16,716 | 23,148 | 6,432 | 1.69% | $337.79K |
| BIOGEN INC | 3,923 | 5,434 | 1,511 | 1.69% | $322.84K |
| GILEAD SCIENCES INC | 5,675 | 7,859 | 2,184 | 1.69% | $222.71K |
| TG THERAPEUTICS INC | 21,799 | 30,187 | 8,388 | 1.67% | $378.17K |
| KRYSTAL BIOTECH INC | 2,792 | 3,866 | 1,074 | 1.67% | $234.26K |
| LEGEND BIOTECH CORP SPON ADR | 30,617 | 42,398 | 11,781 | 1.64% | $461.40K |
| SYNDAX PHARMACEUTICALS INC | 33,549 | 46,457 | 12,908 | 1.64% | $314.19K |
| ARROWHEAD PHARMACEUTICALS INC | 9,749 | 13,501 | 3,752 | 1.63% | $316.16K |
| Ascendis Pharma A/S | 3,100 | 4,293 | 1,193 | 1.62% | $283.82K |
| AGIOS PHARMACEUTICALS INC | 25,060 | 34,703 | 9,643 | 1.60% | $284.04K |
| HALOZYME THERAPEUTICS INC | 10,984 | 15,211 | 4,227 | 1.59% | $180.67K |
| ARDELYX INC | 110,048 | 152,393 | 42,345 | 1.58% | $118.38K |
| BIOMARIN PHARMACEUTICAL INC | 12,818 | 17,750 | 4,932 | 1.57% | $232.17K |
| INCYTE CORP | 7,162 | 9,918 | 2,756 | 1.55% | $228.19K |
| AURINIA PHARMS. INC | 43,117 | 59,707 | 16,590 | 1.51% | $292.10K |
| SAREPTA THERAPEUTICS INC | 31,741 | 43,955 | 12,214 | 1.51% | $272.17K |
| REGENERON PHARMACEUTICALS INC | 921 | 1,276 | 355 | 1.48% | $219.33K |
| BRIDGEBIO PHARMA INC | 9,093 | 12,592 | 3,499 | 1.47% | $192.80K |
| VERTEX PHARMACEUTICALS INC | 1,511 | 2,093 | 582 | 1.47% | $184.49K |
| BEONE MEDICINES LTD ADR | 2,141 | 2,965 | 824 | 1.44% | $146.72K |
| IONIS PHARMACEUTICALS INC | 8,454 | 11,708 | 3,254 | 1.44% | $176.40K |
| CRISPR THERAPEUTICS AG | 12,056 | 16,695 | 4,639 | 1.44% | $271.50K |
| THERAVANCE BIOPHARMA INC | 37,611 | 52,082 | 14,471 | 1.43% | $159.50K |
| MADRIGAL PHARMACEUTICALS INC | 1,194 | 1,655 | 461 | 1.41% | $272.04K |
| KURA ONCOLOGY INC | 66,870 | 92,599 | 25,729 | 1.34% | $274.66K |
| NEUROCRINE BIOSCIENCES INC | 4,472 | 6,192 | 1,720 | 1.34% | $206.84K |
| PTC THERAPEUTICS INC | 9,033 | 12,510 | 3,477 | 1.34% | $131.64K |
| ACADIA PHARMACEUTICALS INC | 25,170 | 34,855 | 9,685 | 1.29% | $149.97K |
| ARCUTIS BIOTHERAPEUTICS INC | 23,549 | 32,610 | 9,061 | 1.24% | $159.77K |
| TARSUS PHARMACEUTICALS INC | 8,399 | 11,632 | 3,233 | 1.22% | $197.84K |
| ALNYLAM PHARMACEUTICALS INC | 1,717 | 2,379 | 662 | 1.21% | $155.83K |
| HARMONY BIOSCIENCES HOLDINGS INC | 16,869 | 23,360 | 6,491 | 1.20% | $114.18K |
| PHATHOM PHARMACEUTICALS INC | 46,937 | 64,997 | 18,060 | 1.20% | $86.34K |
| CRINETICS PHARMACEUTICALS INC | 13,535 | 18,743 | 5,208 | 1.19% | $50.92K |
| Immunocore Holdings plc ADS | 18,569 | 25,714 | 7,145 | 1.18% | $113.26K |
| RHYTHM PHARMACEUTICALS INC | 6,017 | 8,333 | 2,316 | 1.11% | $61.11K |
| INSMED INC | 3,468 | 4,801 | 1,333 | 1.08% | $110.50K |
| ULTRAGENYX PHARMA INC | 18,862 | 26,120 | 7,258 | 1.06% | $190.89K |
| NUVATION BIO INC | 81,068 | 112,261 | 31,193 | 0.82% | $74.77K |
| ESPERION THERAPEUTICS INC NEW | 177,508 | 245,810 | 68,302 | 0.81% | -$110.13K |
| ADMA BIOLOGICS INC | 34,551 | 47,844 | 13,293 | 0.81% | -$107.33K |
| LENZ THERAPEUTICS INC | 37,674 | 52,170 | 14,496 | 0.77% | -$127.52K |
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 1,869,136 | 1,868,134 | -1,003 | 3.07% | -$1.00K |
| Security | Shares Jan 2026 | Shares Apr 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| OMNIAB INC - 12.5 EARNOUT | 1,295 | 1,295 | 0 | 0.00% | $0 |
| OMNIAB INC - 15.00 EARNOUT | 1,295 | 1,295 | 0 | 0.00% | $0 |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.